No Data
No Data
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating, Announces Target Price $30
H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23
Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
Protara Therapeutics Analyst Ratings
Protara Therapeutics' TARA-002 Shows Promising Efficacy and Safety in HR-NMIBC, Earning Buy Rating
Protara Therapeutics (NASDAQ:TARA) Is In A Good Position To Deliver On Growth Plans